Our mission is to bridge the gap between data and discovery. We are committed to delivering cutting-edge bioinformatics solutions that unlock the full potential of biological data, enabling our clients to uncover new biological insights, identify therapeutic targets, and make significant contributions to the advancement of human health, agriculture, and environmental sustainability.
We acknowledge the multitude of challenges encountered by biotech and pharmaceutical startups and are dedicated to delivering premium yet cost-effective bioinformatics services. Our specialized services are meticulously crafted to align with the distinct requirements of startups, and our unwavering dedication to achieving excellence remains unparalleled.
Headquartered in Sweden, A&M Bioinformatics brings together a team of international scientists specialized in a range of areas including NGS data processing, analysis, interpretation, and common genomic data analysis, as well as statistical modelling, data integration, data mining, and database development and management.
Leadership: Dr. Ayman Osman, the company's director, is an experienced computational and molecular biologist holding a PhD in medical sciences and extensive research experience in bioinformatics, epigenetics and molecular biology.
